Search results for " KAP"

showing 10 items of 266 documents

1543P Gemcitabine in classic Kaposi’s sarcoma: A pilot study

2021

Oncologymedicine.medical_specialtyOncologybusiness.industryInternal medicinemedicineClassic Kaposi's sarcomaHematologybusinessGemcitabinemedicine.drugAnnals of Oncology
researchProduct

VII: Diagnosestudien: Einfache Maße für Validität und Reliabilität

2003

The evaluation of a new diagnostic or imaging device has to focus both on its diagnostic validity and reliability. Cohen's kappa coefficient can be used to assess the agreement of the new device's findings with those of an established diagnostic reference, it therefore presents a surrogate measure of validity. Additional measures of validity are sensitivity and specificity, which assess the order of agreement with the reference for positive and negative reference findings, respectively. The latter, however, can only be applied for binary reference findings. If discordant findings are observed, the McNemar test can be used to detect a diagnostic shift between diagnostic novum and reference. …

OphthalmologyMcNemar's testCohen's kappaSIMPLE (military communications protocol)Observer BiasComputer sciencefungiStatisticsMedical imagingDiagnostic validityfood and beveragesValidityReliability (statistics)Klinische Monatsblätter für Augenheilkunde
researchProduct

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

2015

BACKGROUND: Data are lacking on the long-term effect on cardiovascular events of adding sitagliptin, a dipeptidyl peptidase 4 inhibitor, to usual care in patients with type 2 diabetes and cardiovascular disease. METHODS: In this randomized, double-blind study, we assigned 14,671 patients to add either sitagliptin or placebo to their existing therapy. Open-label use of antihyperglycemic therapy was encouraged as required, aimed at reaching individually appropriate glycemic targets in all patients. To determine whether sitagliptin was noninferior to placebo, we used a relative risk of 1.3 as the marginal upper boundary. The primary cardiovascular outcome was a composite of cardiovascular deat…

Oralmedicine.medical_specialtyHeart diseasesGlycosylatedAdministration Oralheart failureType 2 diabetesDipeptidyl peptidase-4 inhibitorKaplan-Meier EstimatePlaceboSitagliptin PhosphateSitagliptin Cardiovascular Outcomeschemistry.chemical_compoundDrug TherapyDouble-Blind MethodInternal medicineDiabetes MellitusmedicineHumansHypoglycemic AgentsGlycated HemoglobinHemoglobin A GlycosylatedAdministration Oral; Cardiovascular Diseases; Diabetes Mellitus Type 2; Double-Blind Method; Drug Therapy Combination; Follow-Up Studies; Heart Diseases; Heart Failure; Hemoglobin A Glycosylated; Hospitalization; Humans; Hypoglycemic Agents; Kaplan-Meier Estimate; Pyrazines; Sitagliptin Phosphate; Triazoles; Medicine (all)business.industryMedicine (all)SemaglutideSitagliptin PhosphateHemoglobin AGeneral MedicineTriazolesta3121medicine.diseaseSurgeryHospitalizationCardiovascular diseaseschemistryDiabetes Mellitus Type 2SitagliptinPyrazinesAdministrationCombinationDrug Therapy CombinationGlycated hemoglobinbusinessType 2Alogliptinmedicine.drugFollow-Up StudiesNew England Journal of Medicine
researchProduct

Comparative analysis of impacted upper canines: Panoramic radiograph Vs Cone Beam Computed Tomography.

2016

Background The use of CBCT exam in the study of IMC is not new. However, it's still not known in what specific aspects CBCT exam shows a better result than then conventional exams. The aim of this study was to compare and conclude in what way the opinion regarding upper canine impaction differed when observing a panoramic image compared to the observation of a set of CBCT reconstructions. Material and Methods Twenty patients (10 males and 10 females) with a total of 28 impacted maxillary canines were identified from the database of the Department of Dentistry, Faculty of Medicine, University of Coimbra. For each canine, two different images were available: a panoramic image and a set of CBC…

OrthodonticsCone beam computed tomographyPanoramic radiographbusiness.industryImpactionImpacted toothResearchDentistryOrthodontics030206 dentistry:CIENCIAS MÉDICAS [UNESCO]03 medical and health sciences0302 clinical medicineCohen's kappaMcNemar's testCronbach's alphastomatognathic system030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASCusp (anatomy)MedicinebusinessGeneral DentistryJournal of clinical and experimental dentistry
researchProduct

Traditional Chinese herbal medicine at the forefront battle against COVID-19: Clinical experience and scientific basis.

2020

Abstract Background Throughout the 5000-year history of China, more than 300 epidemics were recorded. Traditional Chinese herbal medicine (TCM) has been used effectively to combat each of these epidemics’ infections, and saved many lives. To date, there are hundreds of herbal TCM formulae developed for the purpose of prevention and treatment during epidemic infections. When COVID-19 ravaged the Wuhan district in China in early January 2020, without a deep understanding about the nature of COVID-19, patients admitted to the TCM Hospital in Wuhan were immediately treated with TCM and reported later with >90% efficacy. Approach We conducted conduct a systematic survey of various TCM herbal pre…

PTGS2 Prostaglandin-endoperoxide synthase 2BattleAIV avian influenza virusCoV coronavirusPharmaceutical ScienceiNOS nitric oxide synthaseViral infection0302 clinical medicinePA patchouli alcoholSARS Severe Acute Respiratory SyndromeSMD Sheganmahuang decoctionDrug DiscoveryPandemicIL InterleukinMedicine Chinese TraditionalALI acute lung injuriesmedia_commonCOVID-19 coronavirus disease 2019MXSG Ma xing shi gan decoction0303 health sciencesTNF tumor necrosis factorClinical Trials as TopicCCL2 CC chemokine ligand 2FM1 FM1 coronavirusICU intensive care unitc-AMP cyclic adenosine phosphateHIV human immunodeficiency virus030220 oncology & carcinogenesisCOX-2 cyclooxygenase-2Molecular MedicineHerbal preparationsMedicinal herbsAbbreviations: ACE2 angiotensin-converting enzyme IITCM traditional Chinese medicineHSV-1 herpes simplex virus 1CASP3 caspase 3medicine.medical_specialtyChinaCoronavirus disease 2019 (COVID-19)Systematic surveymedia_common.quotation_subjectJEV Japanese encephalitis virusNF-κB nuclear factor kappa B cellsAntiviral AgentsArticleWHO World Health Organization03 medical and health sciencesIEC-6 rat intestinal epithelial cell line 6SOD superoxide dismutaseCDC Center for Disease Control and PreventionmedicineAVP arginine vasopressinPGE2 prostaglandin E2HumansIntensive care medicineLH Lianhuaqingwen capsule030304 developmental biologyPharmacologyMedicinal herbMDA malondialdehydeGCGJ Gancao ganjiang decoctionNO nitric oxidePlants Medicinalbusiness.industrySARS-CoV-2COVID-19CXCL C-X-C- motif chemokineMDCK Madin-Darby Canine Kidney cellsTLR-4 Toll-like receptor-4COVID-19 Drug TreatmentComplementary and alternative medicineViral infectionLPS lipopolysaccharidesRSV respiratory syncytial virusQFPD Qingfeipaidu decoctionbusinessLung congestionECMO extracorporeal membrane oxygenationMAPK mitogen-activated protein kinasePhytotherapyDrugs Chinese HerbalPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

A case of Waldenstroem's disease with a monoclonal IgM antiphospholipid antibody

2002

The antiphospholipid syndrome (APS) was described in 1983 as a clinical entity characterized by venous and arterial thrombosis, thrombocytopenia, and recurrent fetal loss. The serological markers of APS are antiphospholipid antibodies (APLA) directed mainly against anionic phospholipids, usually cardiolipin but also phosphatidylserine. Some APLA exhibit lupus anticoagulant activity. Monoclonal gammopathy sometimes occurs with the presence of autoantibodies. In this paper, we describe a patient with the diagnosis of immunocytoma with an IgM, kappa paraprotein with apparent specificity against anionic phospholipids, and lupus anticoagulant activity, but no clinical signs of APS. We describe i…

Pathologymedicine.medical_specialtyImmunologymedicine.disease_causeSerologyAutoimmunityImmunoglobulin kappa-ChainsRheumatologyimmune system diseasesAntiphospholipid syndromemedicineHumansImmunology and AllergyGlycoproteinsLupus anticoagulantbiologybusiness.industryAutoantibodyWaldenstrom macroglobulinemiaMiddle Agedmedicine.diseaseTreatment OutcomeImmunoglobulin Mbeta 2-Glycoprotein ILupus Coagulation InhibitorImmunologyMonoclonalAntibodies Antiphospholipidbiology.proteinFemaleWaldenstrom MacroglobulinemiaAntibodybusinessParaproteinsRheumatology International
researchProduct

High sensitivity of free lambda and free kappa light chains for detection of intrathecal immunoglobulin synthesis in cerebrospinal fluid.

2008

Background –  So far, an inflammation of the central nervous system (CNS) is diagnosed by immunoglobulin measurement in cerebrospinal fluid (CSF) and serum as well as by determination of the oligoclonal bands. With the free kappa and lambda light chains, new markers to diagnose intrathecal synthesis are available. Methods –  In addition to routine diagnostic tests and the assessment of standard parameters, free immunoglobulin light chains were measured in the CSF of patients with neurological disorders. Results –  A significant agreement was found between an increase in free kappa light chain CSF serum quotients and results of the currently widely applied method of oligoclonal band measurem…

Pathologymedicine.medical_specialtyOligoclonal bandMultiple SclerosisImmunoglobulin MeasurementImmunoglobulinsImmunoglobulin lambda-ChainsImmunoglobulin light chainImmunoglobulin kappa-ChainsSensitivity and SpecificityImmunoglobulin kappa-ChainsCerebrospinal fluidImmunoglobulin lambda-ChainsAlzheimer DiseasemedicineAnimalsHumansAnalysis of VarianceSheepbiologybusiness.industryMental DisordersReproducibility of ResultsGeneral MedicineNeurologyImmunologybiology.proteinDementiaNeurology (clinical)AntibodyNervous System DiseasesbusinessKappaActa neurologica Scandinavica
researchProduct

Latvija. Pārskats par tautas attīstību 2012/2013. Ilgtspējīga nācija

2013

Pārskats par tautas attīstību sagatavots valsts pētījumu programmas «Nacionālā identitāte» ietvaros.

Pensiju sistēma (Latvija)Sabiedrības integrācijaPilsoniskā līdzdalībaFakti (Latvija)Darba tirgusDemogrāfija (Latvija)Sociālais un kultūras kapitālsTeritoriju ilgtspējaSociālā ilgtspēja:SOCIAL SCIENCES [Research Subject Categories]Demogrāfiskā atbalsta politika (Latvija Igaunija)Elektroniskie pakalpojumiInformācijas pieejamībaAptaujas „Nevienlīdzība integrācija un teritoriju ilgtspējīga attīstība LU SZF 2013.” tehniskā informācijaCilvēkkapitālsSociālā drošībaSociālā vienlīdzība
researchProduct

Knowledge, Attitudes, Perceptions and Vaccination Acceptance/Hesitancy among the Community Pharmacists of Palermo’s Province, Italy: From Influenza t…

2022

In Italy, following the start of the SARS-CoV-2 vaccination campaign, community pharmacies (CPs) were recruited on a voluntary basis in order to administer COVID-19 vaccines as part of their activities. The aim of the present study was to investigate the knowledge, attitudes, and practices regarding SARS-CoV-2 infection prevention, and vaccine acceptance/hesitancy towards COVID-19 and influenza vaccinations among the community pharmacists operating in the Palermo Province. A cross-sectional study was conducted, with two different questionnaires administered before and after the conduction of the vaccination campaign against SARS-CoV-2 at the COVID-19 vaccination center of the Palermo Univer…

Pharmacologycommunity pharmacistInfectious DiseasesCOVID-19 vaccinationSARS-CoV-2 infectionhealthcare professionalDrug DiscoveryImmunologyPharmacology (medical)influenza vaccinationvaccine hesitancy.influenza vaccination; COVID-19 vaccination; community pharmacists; KAPs; vaccine hesitancy; healthcare professionals; SARS-CoV-2 infectionVaccines
researchProduct

Opinia prawna na temat beneficjenta rzeczywistego w przypadku spółki kapitałowej, której jedynym (100%) udziałowcem czy akcjonariuszem jest zakon, bą…

2020

Celem niniejszej opinii prawnej jest udzielenie odpowiedzi na pytanie: Kto jest beneficjentem rzeczywistym w przypadku spółki kapitałowej, której jedynym (100%) udziałowcem czy akcjonariuszem jest zakon bądź jego jednostka organizacyjna (prowincja zakonna, opactwo, klasztor niezależny, dom zakonny)? Przeprowadzone analizy przepisów prawa polskiego i prawa kanonicznego prowadzą do wniosku, że w przypadku spółki kapitałowej, której jedynym (100%) udziałowcem czy akcjonariuszem jest zakon bądź jego jednostka organizacyjna (prowincja zakonna, opactwo, klasztor niezależny, dom zakonny) beneficjentem rzeczywistym jest właściwy wyższy przełożony tego zakonu oraz członkowie jego rady. Osoby te speł…

Philosophy. Psychology. Religionzakonbeneficjent rzeczywistyMoney launderingKLegal personBeneficiary (trust)finansowanie terroryzmuCanon lawpranie pieniędzybeneficjent rzeczywisty; spółki kapitałowe; pranie pieniędzy; finansowanie terroryzmu; zakon; prawo kanoniczne; opactwo; spółka kapitałowa; dom zakonny; klasztor niezależny; prowincja zakonnaShareholderPolitical scienceLawTerrorismLegal opinionspółki kapitałoweBprawo kanoniczneLawLimited companyStudia z Prawa Wyznaniowego
researchProduct